期刊文献+

良性前列腺增生的流行病学特征及危险因素研究进展 被引量:67

Epidemiological characteristics and risk factors of benign prostatic hyperplasia:an update
在线阅读 下载PDF
导出
摘要 本文总结了近10年有关良性前列腺增生(benign prostatic hyperplasia,BPH)流行特征和危险因素的重要文献,发现随着人口老龄化的加剧,世界范围内BPH发病率高且呈上升趋势,而中西方BPH发病率的差距正在缩小。BPH病因很多,其中年龄、性激素、前列腺特异性抗原、生长因子、基因多态性、某些疾病如代谢综合征、肥胖症和慢性前列腺炎等是较为明确的危险因素,而吸烟和饮酒不增加患BPH的风险。 The representative literatures on epidemiological characteristics and risk factors of benign prostatic hyperplasia(BPH)in the last 10 years are reviewed.With the increasing aging of population,the incidence of BPH is rising worldwide,as well as in China.Multiple factors are associated with the occurrence of BPH.The age,sex hormone,PSA,cytokines,gene polymorphism,metabolic syndrome,obesity and chronic prostatitis are all incontrovertible risk factors;however,tobacco and alcohol consumption do not increase the risk of BPH.
作者 谢金波 彭波 XIE Jin-bo;PENG Bo(Dept.of Urology,Shanghai Tenth People's Hospital,School of Medicine,Tongji University,Shanghai 200072,China)
出处 《同济大学学报(医学版)》 2021年第4期568-573,共6页 Journal of Tongji University(Medical Science)
基金 国家自然科学基金(81870517) 上海市科学技术委员会科普项目(19DZ2301800)。
关键词 流行病学特征 危险因素 良性前列腺增生 下尿路症状 epidemiological characteristics risk factor benign prostatic hyperplasia lower urinary tract symptoms
  • 相关文献

参考文献7

二级参考文献33

  • 1汪维鹏,倪坤仪,周国华.单核苷酸多态性检测方法的研究进展[J].遗传,2006,28(1):117-126. 被引量:62
  • 2郭应禄,周利群译.坎贝尔-沃尔什泌尿外科学[M].9版.北京:北京大学医学出版社,2009:2866-2867.
  • 3Antonio A,Peter H,Andrea T.Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer?[J].European Urology,2009,55(4):864-875.
  • 4Blauer M,Tammela TL,Ylikomi T.A novel tissue-slice culture model for non-malignant human prostate[J].Cell Tissue Res,2008,2(4):489-498.
  • 5Seiji A,Yasuhiro S,Maebashi et al.Age-related changes of adrenal androgen and estrogen levels in the prostatic tissue with benign prostatic hyperplasia[J].Journal of Urology,2009,4:181.
  • 6Rosebud O,Erik J,Julie M,et al.Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia[J].American Journal of Epidemiology,2004,159:269-276.
  • 7Tindall D,Rittmaster R.The rationale for inhibiting 5 areductaseisoenzymes in the prevention and treatment of prostate cancer[J].Journal of Urology,2008,179:1236-1243.
  • 8Jiri H,Hampl R,Hill M,et al.Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer[J].Steroids,2007,72(4):375-380.
  • 9Prezioso D,Denis LJ,Klocker H,et al.Estrogens and aspects of prostate disease[J].Int J Urol,2007,14:1-16.
  • 10Rohrmann S, Platz EA, Giovannucci E, et al. Lifestyle and benign prostatic hyperplasia in older men:what do we know? [J] .J Men' s Health & Gender, 2005, 2(2) : 230 - 235.

共引文献5511

同被引文献695

引证文献67

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部